New CAR T Cells Could Help Avoid Patient Relapse in Blood Cancers
Up to 30 percent of patients with B cell malignancies such as lymphoma relapse after CAR T cell treatment, partly because their lymphoma cells stop expressing the target antigen
Toxicology
Product News & ResourcesView More
Medications Underused in Treating Opioid Addiction, Expert Says
According to a recent review, the three drugs may be underused in part because access is limited by some legal requirements regarding who can write prescriptions
MultimediaView More
Toxicology ManufacturersView More
See a full list of Toxicology Product Manufacturers
View list